Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy
about
Non-Publication Is Common among Phase 1, Single-Center, Not Prospectively Registered, or Early Terminated Clinical Drug TrialsHope for health and health care.Adolescent perspectives on phase I cancer researchStakeholder views on participant selection for first-in-human trials in cancer nanomedicine."Do not resuscitate" decisions in acute respiratory distress syndrome. A secondary analysis of clinical trial data.Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital.Evaluation of patient enrollment in oncology phase I clinical trials.Participation and survival of geriatric patients in Phase I clinical trials: the Karmanos Cancer Institute (KCI) experience"Until the trial is complete you can't really say whether it helped you or not, can you?": exploring cancer patients' perceptions of taking part in a trial of acupressure wristbandsPerceptions and referral trends into phase I oncology trials: results of a clinical surveyDistress among caregivers of phase I trial participants: a cross-sectional study.Participants' understanding of informed consent in clinical trials over three decades: systematic review and meta-analysis.Outcomes of research biopsies in phase I clinical trials: the MD anderson cancer center experience.Motivators for participation in a whole-genome sequencing study: implications for translational genomics research.Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases.American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.Motivations for participating in a clinical trial on an avian influenza vaccinePRognostic factor of Early Death In phase II Trials or the end of 'sufficient life expectancy' as an inclusion criterion? (PREDIT model).Patients' willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey.Oncologists' recommendations of clinical trial participation to patientsThe ethical use of mandatory research biopsiesThe culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials.Patients' willingness to participate in a breast cancer biobank at screening mammogram.The ethics of withdrawal from study participation.Maternal participant experience in a South African birth cohort study enrolling healthy pregnant women and their infants.Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies.The effects of cancer research participation on patient experience: a mixed-methods analysis.Clinical trial participation as part of end-of-life cancer care: associations with medical care and quality of life near death.Early oncology clinical trial design in the era of molecular-targeted agents.Recommendations for enhancing clinical trials education: a review of the literature.Cancer patients' trust in their physician-a review.Moral justification of Phase 1 oncology trials.Cancer patient decision making related to clinical trial participation: an integrative review with implications for patients' relational autonomy.A Qualitative Study of Decision-Making on Phase III Randomized Clinical Trial Participation in Pediatric Oncology: Adolescents' and Parents' Perspectives and Preferences.Influence of early phase clinical trial enrollment on patterns of end-of-life care for children with advanced cancer.Understanding how coping strategies and quality of life maintain hope in patients deliberating phase I trial participation.A qualitative assessment of the experience of participating in a cancer-related clinical trial.Quality of life as an endpoint in Phase I oncology clinical trials of novel chemotherapy drugs.Frequency and Predictors of Acute Hospitalization Before Death in Patients With Glioblastoma.Attitudes toward participating in Phase I clinical trials: an investigation with patient-family-physician triads.
P2860
Q28555016-94465858-C9A8-4462-98DC-E7D34AB04C20Q30362763-9A21061F-482A-4998-A78F-233BA629ECF3Q30531481-76B02099-3E13-40CF-A3B0-4596D785F4BEQ30832708-0AC27FC9-2A91-46E9-8992-D6CC746502D6Q30868744-183F59CC-7B29-4DE3-A746-819B3F6053B8Q33263052-AA30CA7A-7AB5-4C91-A7B4-5FD22AE95FACQ34594562-B9E9EB07-1F87-4A97-B7F2-76F1844C4A0EQ34801461-D8688253-B658-4EFC-8B7F-F9B16C8A87C2Q35011297-8D365151-1372-4214-AEE7-75053C540E8BQ35104935-A5DD313B-4DC0-413E-85A6-31D48A0ADB03Q35166609-AE56FF16-4DA3-4E45-A948-35431F54E736Q35211304-F1193FFB-5A0C-4EE5-ADC8-362A17013A5FQ35584811-4E5EEF9A-74B9-428E-8AC5-3824B09C0E3AQ35591689-D01AE56E-F7E0-452A-AE74-AAD111A1F7D6Q35745601-2B02518E-5DE3-41DE-B312-80615309851DQ35894574-E008745B-6DAB-4FE2-A985-592535A77F30Q35945862-493285F4-477E-4D3B-B662-E757C345C9FDQ36157118-B7062733-AFEB-47C2-A4B1-346F5FB1F07DQ36446227-F767A9B2-5CE5-4422-9BF1-67A6B35C3411Q36470363-34ECFACF-A27B-4499-94A5-6B9DC2C6D716Q36783493-345FD737-F708-4551-9F6A-A832529E72C0Q36818341-07E35111-5A70-42E1-AA21-91B5259A8C64Q36911942-0C2B39E5-7608-4801-810E-7166ACE9F305Q36938112-548D290C-C0A0-421C-B4CA-0C7758B1712AQ37111317-5BE77DE3-5B84-478B-8A9B-BCB0CCD212CCQ37342909-D7F50088-2149-48C7-8962-4E1F3099B734Q37394054-7E84D12E-F0FD-4EDF-B6EB-62CB78E89014Q37686819-100AE949-32A6-4139-A2ED-3E474B2ABAECQ37783623-E4909E79-6C0E-43E2-B6FB-5924B5D5E16BQ37791483-23F59A7A-D706-402B-A67A-F0F5E3D44B5BQ37794093-743A7944-0B28-4CD2-9481-01CBB406B3D0Q38210627-1AD6F367-5C6F-4C00-963F-7A08D99C2065Q38319483-E0F9EDC6-B7C7-4991-B048-46D2F1AD6D9FQ38644166-BE1EA2F9-9950-41D2-BDFC-F9EDD488F875Q38647531-FF981EF1-E464-4F50-8344-E6D9966565DFQ38700608-559101D3-B226-4005-9BF0-AB311DF2AD63Q39294734-120157E7-57D1-421C-9B06-83C17623E616Q40385066-0D5D6EF4-26F0-44E5-AC66-3250132A42F4Q40490895-2BD42C55-91A6-48B5-ABF9-52669D3DD2CFQ40563636-E5175AAE-3F07-4A34-8B16-93EBD5C97D24
P2860
Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Patient motivations surroundin ...... trials of cancer chemotherapy
@ast
Patient motivations surroundin ...... trials of cancer chemotherapy
@en
type
label
Patient motivations surroundin ...... trials of cancer chemotherapy
@ast
Patient motivations surroundin ...... trials of cancer chemotherapy
@en
prefLabel
Patient motivations surroundin ...... trials of cancer chemotherapy
@ast
Patient motivations surroundin ...... trials of cancer chemotherapy
@en
P2093
P2860
P921
P356
P1476
Patient motivations surroundin ...... trials of cancer chemotherapy
@en
P2093
J D Bissett
M C Nicolson
N C Campbell
Z A Nurgat
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602423
P407
P577
2005-03-01T00:00:00Z